Molecular biomarkers in stroke recovery: Consensus-based core recommendations from the fourth Stroke Recovery and Rehabilitation Roundtable
Authors:
- Matthew A EdwardsonMEMatthew A Edwardson
- Robynne G BraunRBRobynne G Braun
- Chad M AldridgeCAChad M Aldridge
- Rufus AkinyemiRARufus Akinyemi
- Stefan T EngelterSEStefan T Engelter
- Israel Fernández-CadenasIFIsrael Fernández-Cadenas
- Cristina Gallego-FabregaCGCristina Gallego-Fabrega
- Quentin Le GrandQGQuentin Le Grand
- Alexander H NaveANAlexander H Nave
- Rajiv RatanRRRajiv Ratan
- Bradford B WorrallBWBradford B Worrall
- 18 August 2026
- journal article
- Published by SAGE Publications in International Journal of Stroke
Abstract
Rationale: The 2017 Stroke Recovery and Rehabilitation Roundtable (SRRR) consensus statement on biomarkers identified genetic and blood biomarkers as a developmental priority for stroke recovery and rehabilitation. While progress has been made, this nascent field still lags behind other medical disciplines. Further development is critical because molecular biomarkers hold great promise to provide key insights into the neurobiological mechanisms of both spontaneous and treatment-induced stroke recovery. Such insights could lead to effective recovery biotherapeutics and help optimize the timing and delivery of therapies. Methods: A multidisciplinary taskforce of international experts with expertise in omics and stroke recovery identified and prioritized key focus areas. Consensus opinion was developed across 15 virtual meetings, 2 rounds of anonymous polling and a 2-day in-person meeting. Key recommendations were iteratively refined until full consensus was achieved by all taskforce members. Results: Our main recommendation is that there is a critical need for large-scale, multi-center, discovery-based omics studies to identify molecular targets in stroke recovery. To help achieve this goal we suggest ways to harmonize future studies including timepoints for data collection, outcome measures, and biospecimen selection. In addition, we address the limitations of current candidate biomarkers, translational challenges, emerging technologies, biomarker response to interventions, multi-site collaboration, and ethical concerns. Conclusions: There is a great need for collaborative efforts by the international neurorehabilitation community to collect and harmonize molecular biomarker data. The resulting discoveries will be foundational to precision neurorehabilitation and the development of recovery biotherapeutics to enhance recovery for stroke survivors.Keywords
Funding Information
- Moleac
- UK Stroke Forum and Stroke Association
- CanStroke Recovery Trials group
This publication has 53 references indexed in Scilit:
- Biomarkers for advancing diagnosis and prognosis in strokeThe Lancet Neurology, 2026
- Levodopa Added to Stroke RehabilitationJAMA, 2025
- Multi-Omics Approaches to Discovering Acute Stroke Injury and Recovery Mechanisms2024
- Role of PATJ in stroke prognosis by modulating endothelial to mesenchymal transition through the Hippo/Notch/PI3K axisCell Death Discovery, 2024
- A systematic review exploring the association between the human gut microbiota and brain connectivity in health and diseaseMolecular Psychiatry, 2023
- Untargeted metabolomics predicts the functional outcome of ischemic strokeJournal of the Formosan Medical Association, 2021
- Circulating Metabolites Differentiate Acute Ischemic Stroke from Stroke MimicsAnnals of Neurology, 2020
- Association BetweenCYP2C19Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic AttackJAMA, 2016
- Plasticity during stroke recovery: from synapse to behaviourNature Reviews Neuroscience, 2009
- Outcome and time course of recovery in stroke. Part II: Time course of recovery. The copenhagen stroke studyArchives of Physical Medicine and Rehabilitation, 1995